Pharmacokinetics of Subcutaneous Injection (SC)of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy Volunteers
Phase 3
Completed
- Conditions
- Male HypogonadismMetabolic and Endocrine - Other metabolic disorders
- Registration Number
- ACTRN12613000068763
- Lead Sponsor
- Sydney Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 8
Inclusion Criteria
Inclusion:
*Healthy male volunteers
*Aged 18-55 yr
*Written, informed consent & willing to comply with study requirements
Exclusion Criteria
*Contraindication to nanadrolone
*Seeking fertility in the next year
*Involved in any professional or recreational activities requiring urine drug screening
*History of illicit drug abuse within last year
*History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements
*Regular medications that interfere with absorption, metabolism or action of testosterone
* Taking medications for antiplatelet or anticoagulant therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method